7 / 32
ARCHBOLD.ORG
•
SPRING 2016
7
in the state of Georgia. The partnership
will complement an already robust
clinical research program at the Singletary
Oncology Center—a program that is
currently accepting patients for nine of
17 existing clinical trials and registries.
Through the partnership with Winship,
eligible Archbold oncology patients
will now have access to more than
250 existing therapeutic clinical trials and
research by top clinicians and researchers
from around the world—in many cases
without having to travel to metro Atlanta
or other large cities for access to cutting-
edge investigative treatments.
Benefit from direct access
“The clinical research partnership with
Emory is such a great thing for patients
in our region,” said Archbold Oncology
Clinical Research Director Teresa
Coleman, MD. “Our existing program is
already very strong and currently offers
more trials than any hospital in the
South Georgia/North Florida region.
Through the Winship network, Archbold
oncology patients will now have access
to the largest unit in Georgia for phase I
clinical trials, which are very important
in introducing new therapies against
cancer. It’s really incredible what this
partnership will mean for patients in our
region.”
Archbold physicians and patients will
benefit from direct access to Winship’s
multidisciplinary cancer meetings for col-
laboration in cancer treatment. Archbold
physicians, nurses and clinical research
staff can also leverage opportunities for
specialized training at Winship.
‘We’re very proud’
Emory’s Winship Cancer Institute is
ranked in the top 25 cancer care centers
in the country, according to
U.S. News &
World Report
, and has improved access
to high-quality cancer care, the newest
research, and continuing patient and
provider education for affiliate partners
like Archbold.
“We are very excited to join forces with
the excellent physicians and clinical staff
at Archbold,” said Walter J. Curran Jr., MD,
Winship’s Executive Director. “Patients
will benefit from access to expedited
second opinions for selected patients
and to enrollment in selected Winship
clinical trials while receiving treatment
and therapy through their local doctors
close to home.”
“Archbold patients have always had
access to state-of-the-art treatments
and technology provided by some of
the most knowledgeable and dedicated
physician specialists in our region,”
said Becky Troyer, Singletary Oncology
Center Administrator. “We’re committed
to remaining ahead of the curve and
providing the best treatment options
for our patients. We have great respect
for the research team and physicians at
Emory, and the partnership will help us
take our already sophisticated clinical
trials program to the next level, which
will result in many more options for our
patients. We’re very proud of what the
partnership with Emory will mean to
oncology patients in our region.”
Lisa Speigner, RN
Clinical Research Nurse
Singletary Oncology Center
Teresa Coleman, MD
Medical Oncologist
Clinical Research Director
Singletary Oncology Center
Josh Simmons, MD
Medical Oncologist
Associate Medical Director
Singletary Oncology Center